Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

950

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Stroke
Interventions
DRUG

Alprostadil

"Alprostadil injection USP for intravascular infusion contains 500 micrograms Alprostadil, more commonly known as prostaglandin E1. Vasodilation, inhibition of platelet aggregation are among the most notable of these effects.~2ml Alprostadil injection added into 10ml 0.9% saline."

DRUG

Normal saline

2ml normal saline injection added into 10ml 0.9% saline.

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER

NCT03252626 - Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter